Coherus BioSciences Inc
Statements
Cash Flow
Coherus BioSciences Inc (CHRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -120 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -62 | -87 | -73 | -56 | -42 | -30 | -34 | -36 | -43 | -47 | -57 | 13 | 55 | 18 | 13 | 60 | 47 | 33 | 1.4 | -0.2 | 14 | -52 | -54 | -50 | -37 | -100 | -69 | -39 | -54 | -13 | -47 | 60 | -62 | 29 | -26 | -47 | -46 | -20 | -58 | -120 | -244 | |
| 0.8 | 0.8 | 0.9 | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.8 | 0.6 | 0.7 | 0.7 | 0.8 | 1.1 | 1.1 | 0.7 | 0.7 | 1.8 | 0.8 | 0.9 | 0.9 | 1.4 | 0.8 | 0.9 | 1.0 | 1.1 | 0.9 | 0.9 | 0.9 | 1.1 | 1.5 | 1.2 | 1.5 | 1.0 | 1.0 | 1.0 | 1.0 | 2.1 | 0.9 | 1.7 | 5.7 | |
| 8.3 | 7.7 | 7.8 | 9.1 | 8.2 | 11 | 8.7 | 8.7 | 8.6 | 8.8 | 9.5 | 8.0 | 8.8 | 7.3 | 9.6 | 9.4 | 9.3 | 9.9 | 17 | 12 | 12 | 11 | 13 | 14 | 12 | 12 | 12 | 10 | 10.0 | 11 | 7.3 | 7.2 | 6.9 | 6.4 | 5.4 | 5.4 | 3.4 | 11 | 2.4 | 5.0 | 22 | |
| 6.7 | 30 | 8.2 | 6.1 | 8.5 | 38 | 8.9 | 5.3 | 12 | 8.8 | 9.5 | 8.0 | 8.8 | 7.8 | 9.6 | 9.4 | 9.3 | 9.9 | 20 | 3.5 | 17 | 62 | 19 | 14 | 38 | 12 | 16 | 9.7 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -154 | -20 | -7.8 | -7.3 | 7.9 | 2.1 | 0.6 | 1.7 | 2.6 | 5.5 | -48 | -20 | -2.8 | -42 | -34 | -15 | 5.4 | 5.8 | 6.4 | 24 | 32 | -21 | -17 | -16 | 8.7 | -55 | -9.3 | -6.2 | -28 | 6.4 | -11 | 74 | -62 | 55 | 11 | -24 | -9.4 | -13 | -24 | -56 | -102 | |
| 0.5 | 3.6 | 1.7 | 1.0 | 1.8 | 0.1 | 0.1 | 0.0 | 0.5 | 0.2 | 0.3 | 0.2 | 0.9 | 0.4 | 1.8 | 2.4 | 2.1 | 1.0 | 0.1 | 0.4 | 0.3 | 0.5 | 0.6 | 0.9 | 0.5 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.5 | -3.6 | -52 | 4.1 | 29 | 14 | -13 | -17 | 13 | 16 | -15 | 8.8 | -0.3 | -6.1 | -1.6 | -239 | 16 | 210 | -285 | 24 | 16 | 107 | -36 | -0.9 | -0.5 | -130 | 18 | 41 | 51 | 35 | 203 | 28 | 0.4 | -0.5 | -17 | 463 | -67 | -2.8 | 31 | 60 | 21 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 49 | 0.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -0.3 | 0.5 | 0.5 | -0.2 | 0.1 | 0.0 | 0.1 | 0.9 | 1.1 | 1.6 | 0.4 | 2.8 | 3.8 | -0.8 | -0.9 | 5.9 | 4.9 | 5.7 | -1.7 | 47 | 1.3 | 0.0 | -2.7 | -0.6 | -0.3 | -0.1 | -2.8 | -0.3 | -0.2 | 3.3 | -0.7 | -1.7 | 0.0 | 0.0 | -0.3 | – | 0.0 | -0.3 | – | – | – | |
| – | 100 | – | – | – | – | – | 73 | 73 | 73 | 73 | 0.2 | -0.1 | 205 | 205 | 223 | -0.7 | -0.1 | -0.7 | -0.7 | -0.7 | -0.7 | 0.4 | 49 | 49 | – | – | – | – | – | – | – | -0.1 | 0.0 | – | – | 0.0 | -48 | – | – | – | |
| 1.3 | 56 | 125 | -0.2 | 75 | 6.9 | 1.9 | 100 | 1.1 | 2.6 | 81 | 3.0 | 3.7 | 1.2 | 3.9 | 210 | 4.1 | 5.5 | 2.4 | 47 | 1.1 | 1.5 | -1.9 | 0.7 | 49 | 6.6 | 3.8 | 54 | 11 | 0.4 | 0.9 | -188 | -0.2 | 0.2 | -0.3 | -282 | 0.0 | 8.1 | 54 | 54 | 115 | |
| -61 | -35 | 0.0 | -52 | 62 | -8.6 | -45 | 48 | -29 | -29 | 9.2 | 24 | 58 | 13 | 16 | 31 | 68 | 249 | -282 | 70 | 31 | 57 | -92 | -50 | 11 | -223 | -47 | 57 | 7.4 | 22 | 157 | -101 | -62 | 28 | -44 | 134 | -114 | -14 | 26 | -6.0 | -108 | |
| -62 | -90 | -75 | -57 | -43 | -30 | -34 | -36 | -43 | -48 | -57 | 12 | 54 | 17 | 12 | 58 | 45 | 32 | 1.2 | -0.6 | 13 | -53 | -55 | -51 | -38 | -100 | -69 | -39 | -54 | -13 | -47 | 60 | -62 | 29 | -26 | -47 | -46 | -20 | -58 | -120 | -244 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.